Sign inJoin waitlistJoin the waitlist

HC

Henry Conter

Medical Oncology

Credentials: ·

History

University of Texas M D Anderson Cancer Center
2014–2016
University of Texas M D Anderson Cancer Center
2011–2014
Medical School
2007–2011

Research

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell…
The Lancet Oncology · 2019 · 1,417 citations
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
Journal of Thoracic Oncology · 2020 · 513 citations
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
European Urology · 2022 · 71 citations

NB
Naveen Basappa
5 papers
Evan Yu
3 papers
GG
Geoffrey Gotto
3 papers
Leonard Appleman
3 papers
AL
Aly-Khan Lalani
2 papers · 2 as a resident
Maen Hussein
2 papers
WB
William Berry
2 papers
AB
Adam Brufsky
1 paper
AS
Ahad Sadiq
1 paper
AS
Alfredo Santillan-Gomez
1 paper
BS
Beth Sieling
1 paper
Chaan Ng
1 paper